Novartis Investigative Site

Mecidiyekoy/Istanbul 34394

0 studies enrolling now · 5 studies all time

What they study most

Adenocarcinoma, Carcinoma, Chronic Kidney Disease (CKD), Chronic Obstructive Pulmonary Disease, End Stage Renal Disease (ESRD), Hemodialysis, Hypernephroid, Liver Transplantation, Nephroid Carcinoma, Renal Cell, Renal Replacement Therapy, Renal Transplantation

Studies at this site

• Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND) — Completed
• Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants — Completed
• Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM) — Completed
• Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer — Completed
• A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD) — Completed